Chinese expert consensus on the diagnosis and management of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy 2022
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy(CADASIL)is a rare cerebral small vessel disease.In order to provide up-to-date recommendations for the clinical diagnosis and treatment of CADASIL,and thus further improve the standardization of clinical practice,the Chinese expert consensus on the diagnosis and management of CADASIL 2022 is approved by the Chinese Society of Neurology,Chinese Stroke Society.This expert consensus adopts the grading of recommendations assessment,development and evaluation system,fully considering the wishes and values of patients,and comprehensively weighing safety,effectiveness,feasibility,accessibility,cost-effectiveness and other factors to form corresponding recommendations for 11 clinical issues regrading CADASIL diagnosis,treatment and prognosis,hoping the formulation of this expert consensus will help to further standardize the diagnosis and treatment of CADASIL in China.
NETL
NSTL
万方数据
